Anika Therapeutics, Inc. (ANIK) Tops Q1 Revenue Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq futures slide as Alphabet results intensify AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.55 --0%
EPS Growth %: +950.0%
Financial Fact:
Basic weighted average common shares outstanding: 14.63M
Today's EPS Names:
ITGR, CARE, CCB, More
EPS Growth %: +950.0%
Financial Fact:
Basic weighted average common shares outstanding: 14.63M
Today's EPS Names:
ITGR, CARE, CCB, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q1 EPS of $0.97, $0.72 better than the analyst estimate of $0.25. Revenue for the quarter came in at $34 million versus the consensus estimate of $16.03 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InterDigital (IDCC) Tops Q3 EPS by 177c ; Offers Guidance
- Arrow Financial (AROW) Tops Q3 EPS by 3c
- Mastercard beats estimates as revenue climbs 14%
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
